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Objectives: HLA-C*07:66 is a low-incidence HLA-C allele. The aim of the study is to report the Taiwanese
and mainland Chinese ethnicities of individuals with C*07:66, together with its uniqueness and
polymorphism.
Materials and Methods: A sequence-based typing method was employed to conﬁrm this low-incidence
allele. Polymerase chain reaction was performed to amplify exons 2, 3, and 4 of the HLA-A, HLA-B,
and HLA-C loci and exon 2 of the HLA-DRB1 and HLA-DQB1 loci using group-speciﬁc primer sets. The
amplicons were sequenced in both directions using BigDye Terminator Cycle Sequencing Ready Reaction
kit. The blood donors in this study consisted of randomized Taiwanese and mainland Chinese individuals
and family members with the C*07:66 allele.
Results: The DNA sequence of C*07:66 is identical to that of C*07:02:01:01 for exons 2, 3, and 4, except
for residue 688 in exon 4. This nucleotide substitution causes a single amino acid alteration to the protein
sequence of C*07:02:01:01. Conﬁrmation of the DNA and protein sequences of C*07:66 and the Taiwa-
nese and mainland Chinese ethnicities of individuals with this allele were established in this study. One
probable HLA C*07:66-associated HLA haplotype may be deduced from these individuals.
Conclusion: The information on the ethnicity of the C*07:66 allele and the deduced probable HLA
haplotype associated with the low-incidence C*07:66 allele reported in this study may aid in HLA testing
laboratories for reference purposes. In addition, they can be used by stem cell transplant donor search
coordinators to help create, for patients bearing this uncommon HLA allele, strategies for ﬁnding
compatible donors using bone marrow donor registries comprising unrelated individuals.
Copyright © 2016, Buddhist Compassion Relief Tzu Chi Foundation. Published by Elsevier Taiwan LLC.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/4.0/).1. Introduction
New HLA alleles continue to be revealed and the recognition of
HLA low-incidence alleles has enriched our understanding of the
complexity of the HLA system. The major histocompatibility com-
plex (MHC) in humans consists of several gene loci that are located
on the short arm of chromosome 6 at 6p21.3. These loci are clas-
siﬁed into MHC class I, class II, and class III regions. The genesells Centre, Hualien Tzu Chi
n 970, Taiwan. Tel.: þ886
).
lief Tzu Chi Foundation. Publishedencoding the HLA alleles are located in the MHC class I and class II
regions. HLA genes are characterized by their extreme allelic
polymorphism as well as their variations and diversity across
different ethnic groups. HLA molecules have been deﬁnitively
deﬁned as transplant antigens and have a strong relevance when
performing tissue transplantation. The molecular similarity of
these molecules between donors and recipients is considered to be
a predictive factor for graft survival and graft versus host disease. It
is imperative to precisely characterize any unknown and low-
incidence alleles encountered during routine HLA typing practice.
To facilitate successful and comprehensive unrelated bone marrow
hematopoietic stem cell donor search when patients are in need of
hematopoietic stem cell transplantation, persistent efforts are
needed to resolve unidentiﬁed, ambiguous, or low-incidence alleles
to offer optimal HLA matching and donor selection.by Elsevier Taiwan LLC. This is an open access article under the CC BY-NC-ND license
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detected in a Chinese individual with Han ethnicity, was ﬁrst sub-
mitted to GenBank (accession number FJ629179) and the IMGT/HLA
Database (submission number HWS10005968) in 2009, and the
name HLA-C*07:66 was ofﬁcially assigned by the World Health
Organization HLA Nomenclature Committee [1]. A family study
indicated that C*07:66 segregated as A*24:02- C*07:66-B*40:01-
DRB1*12:02 haplotype [2]. Here we report the Taiwanese and
mainland Chinese ethnicities of individuals bearing C*07:66 and
the deduced probable HLA haplotypes found to be associated with
C*07:66 based on HLA-A, HLA-B, HLA-C, and HLA-DRB1 alleles
commonly shared across our randomized unrelated donors and
family members with the C*07:66 allele. We further speculate that
the deduced plausible HLA haplotypes associated with C*07:66 are
restricted to individuals who are members of the Chinese or
Taiwanese ethnic groups. In addition, through four family studies,
we found that DRB1*12:02, present in the haplotype A*24:02-
C*07:66-B*40:01-DRB1*12:02, is associated with DQB1*03:01.
2. Materials and Methods
Peripheral whole blood samples from a range of Taiwanese and
Chinese ethnicity individuals were collected in acid citrate dextrose
anticoagulant. A formal written consent was obtained from all the
donors prior to blood collection. Whole blood samples with the
anticoagulant were stored at e80C until use. Peripheral blood
genomic DNA was extracted using QIAamp DNA Blood Mini kits
(Qiagen, Hilden, Germany), according to the manufacturer’s in-
structions. The DNA obtained was subjected to HLA genotyping for
the HLA-A, HLA-B, HLA-C, HLA-DRB1, and HLA-DQB1 loci using
commercial polymerase chain reaction sequencing-based typing kitsFig. 1. The DNA sequence of C*07:66 is identical to C*07:02:01:01 in exons 2, 3 and 4 exce
substituted by A (shaded) in C*07:66. Exons 2, 3 and 4 are separated by pipes (j) between nuc
with C*07:02:01:01.(Secore A/B/C/DRB1/DQB1 Locus Sequencing kits, Life Technologies,
Brown Deer, WI, USA). High-resolution allelic sequencing was per-
formed, as previously described [3e8]. Two sets of primer sequences
were used. These were ﬁrstly B-CG: M13-BIN1-CGG (sense):
TGTAAAACGACGGCCAGTCGGGGGCGCAGGACCCGG and P30 exon 5B
(anti-sense): GCTCCGATGACCACAACTGCT and secondly B-TA: M13-
BIN1-TGA (sense): TGTAAAACGACGGCCAGTGGCGGGGGCGCAG-
GACCTGA and P30exon 5B (anti-sense): GCTCCGATGACCACAACTGCT.
The amplicons were subsequently sequenced in both directions us-
ing a BigDye Terminator Cycle Sequencing Ready Reaction kit
(Applied Biosystems, Foster City, CA, USA) by following the manu-
facturer's instructions.
Determination of the deduced C*07:66-associated probable HLA
haplotype in this study was performed by looking at the commonly
shared HLA typing of the donors bearing C*07:66 across a sample of
the randomized unrelated donors and family members. Where
applicable, haplotype deduction based on HLA allelic homozygos-
ity, as described previously, was employed [9,10].3. Results
In this study, the oriental ethnicity of individuals with C*07:66
was identiﬁed. In addition, the study by Deng et al [2] is conﬁrmed,
which reported that the DNA sequence of C*07:66 is identical to
that of C*07:02:01:01 in exons 2, 3, and 4 except for residue 688 (at
codon 206; CTG->ATG) in exon 4 where cysteine (C) of
C*07:02:01:01 is substituted by alanine (A) in C*07:66 (Fig. 1). This
nucleotide replacement leads to an amino acid exchange wherein
leucine (L) of C*07:02:01:01 is changed to methionine (M) in
C*07:66 (Fig. 2).pt for residue 688 (at codon 206; underlined) in exon 4 where C of C*07:02:01:01 is
leotides 343 and 344 and 619 and 620 respectively. Dashes indicate nucleotide identity
Fig. 2. The nucleotide replacement, described in the Fig. 1, leads to the exchange of one amino acid at residue 206 where leucine (L) of C*07:02:01:01 is changed to methionine (M)
(shaded) in C*07:66.
Table 1
The deduced probable HLA-A, HLA-B, HLA-C, and HLA -DRB1 haplotypes in associ-
ation with C*07:66 were determined based on the HLA typing of individuals who
were either Taiwanese or mainland Chinese (cell number preceded with TB). The
two cells (underlined) were reported to the IMGT/HLA Database. In all cases (except
Cell 7550800383), C*07:66 can be seen to be linked consistently with B*40:01
(shaded). However, when the HLA-A and HLA-DRB1 alleles are considered, C*07:66
is not strictly associated with any particular HLA-A or HLA-DRB1 allele at the HLA-A
and HLA-DRB1 loci, respectively. Only a few individuals carry the probable deduced
HLA haplotype A*24:02-B*40:01-C*07:66-DRB1*12:02 (shaded). Interestingly, Cell
7550800383 carries C*07:66 without having an association with A*24:02 or
DRB1*12:02.
Donor ID HLA-A* HLA-B* HLA-C* HLA-DRB1*
105607 02:01 02:07 13:01 40:01 03:04 07:66 12:02 12:02
189303 02:07 24:02 40:01 03:04 07:66 12:02 15:01
227938 02:07 11:01 40:01 55:02 07:66 12:03 09:01 12:02
267106 24:02 33:03 40:01 58:01 03:02 07:66 03:01 12:02
280478 24:02 33:03 40:01 58:01 03:02 07:66 03:01 12:02
384041 24:02 33:03 40:01 51:01 07:66 14:02 09:01 12:02
376390 11:01 24:02 15:XX 40:01 07:66 08:01 09:CTZ 15:01
228659 02:03 24:02 38:02 40:01 07:02 07:66 04:10 16:02
TB10380 24:02 66:01 40:01 41:02 07:66 17:03 12:02 13:01
TB10602 02:01 24:02 40:01 40:01 04:03 07:66 12:02 15:01
TB02766 02:01 11:02 15:11 40:01 03:03 07:66 12:02 14:54
TB04740 02:07 24:02 40:01 46:01 01:02 07:66 04:05 09:01
TB06710 11:01 24:02 40:01 48:01 07:66 15:02 12:02 15:01
TB07554 02:64 24:02 15:18 40:01 07:04 07:66 04:01 12:02
TB09048 02:06 24:02 35:01 40:01 03:03 07:66 12:02 15:01
TB09049 11:01 24:02 39:15 40:01 07:66 15:02 12:02 12:02
TB00140 02:07 24:02 40:01 46:01 01:02 07:66 09:01 12:02
TB02350 24:02 24:02 40:01 40:06 07:66 08:01 08:03 12:02
TB02467 24:02 33:03 40:01 58:01 03:02 07:66 03:01 12:02
TB04142 02:01 11:01 40:01 48:01 07:66 15:02 12:02 15:01
K.-L. Yang, Z.-Z. Zheng / Tzu Chi Medical Journal 28 (2016) 139e142 141Table 1 shows a total of 30 unrelated and related individuals
bearing C*07:66 obtained from Taiwan, mainland China, and the
IMGT/HLA Database [1]. It can be observed that C*07:66 is almost
always in association with B*40:01 in the HLA-B locus except for
donor 7550800383 of the IMGT/HLA Database [1], which indicates
that there is a strong linkage between the alleles C*07:66 and
B*40:01. In the HLA-A locus, A*24:02 is found predominately to be
associated with C*07:66, followed by A*02:07 and A*11:01, and then
various other HLA-A alleles (Table 1). Similarly, in the HLA-DRB1
locus, DRB1*12:02 is the most frequently observed allele associ-
ated with C*07:66; however, many other HLA-A and DRB1 alleles
also coexist with C*07:66. Based on the above observation, a prob-
able C*07:66 associationwith an HLA-A/B/C/DRB1 haplotypemay be
deduced in the form of A*24:02-C*07:66-B*40:01-DRB1*12:02. This
deduced probable C*07:66-associated haplotype is in fact identical
to the C*07:66-associated haplotype reported in the family study
conducted by Deng et al [2]. However, we are unable to deduce
further probable HLA-A/B/DRB1 haplotypes that are in association
with C*07:66 conclusively; this is because of the inconsistent pres-
ence of various alleles at the HLA-A and HLA-DRB1 loci. Table 2
shows the HLA-A, HLA-B, HLA-C, HLA-DRB1, and HLA-DQB1 typing
of four family members with C*07:66 and of one of the C*07:66
positive donors reported to the IMGT/HLA Database as listed in
Table 1. A commonly shared C*07:66-associated HLA haplotypewith
DQB1*03:01 may be deduced from these family members to be
A*24:02-C*07:66-B*40:01-DRB1*12:02-DQB1*03:01. It is clear that
the DRB1*12:02 allele within haplotype A*24:02-C*07:66-B*40:01-
DRB1*12:02 is in linkage with DQB1*03:01.TB04961 02:07 24:02 15:11 40:01 03:03 07:66 12:02 15:01
TB05020 24:02 26:01 15:02 40:01 07:66 08:01 12:02 12:02
TB05367 02:06 02:07 40:01 40:01 07:02 07:66 09:01 12:01
TB05921 24:02 33:03 40:01 58:01 03:02 07:66 03:01 12:02
TB05923 24:02 24:02 13:01 40:01 03:04 07:66 04:05 12:02
TB07316 01:01 24:02 15:17 40:01 07:01 07:66 12:02 13:02
TB07317 01:01 24:02 15:17 40:01 07:01 07:66 12:02 13:02
TB07318 24:02 24:02 40:01 40:01 03:04 07:66 12:02 16:02
SZBM02 11:01 24:02 07:02 40:01 07:66 07:67 01:01 12:02
7550800383 02:01 31:01 15:01 15:11 07:66 07:67 14:54 15:014. Discussion
In this study, the Taiwanese and mainland Chinese ethnicities of
individuals with C*07:66 was determined and conﬁrmed. Accord-
ing to the Allele Frequency Net Database, C*07:66 has not been
detected among the United States-based National Marrow Donor
Program (NMDP) donors with African American, Asian Paciﬁc
Islander, Caucasian, Hispanic, or Native American ethnicities [11].
Therefore, the restriction of C*07:66 to Taiwanese and mainland
Chinese populations indicates the ethnicity uniqueness of the
allele. In other words, its conservation within individuals of
Taiwanese and mainland Chinese descent is in contrast to many
other HLA alleles, which are widely distributed across all races. The
fact that C*07:66 has a tight association with B*40:01 further sup-
ports the unique nature of this allele and its speciﬁc characteristics.
From a panel of 29 individuals with C*07:66 (Cell 7550800383
excluded; Table 1), we deduced a probable C*07:66-associated HLAhaplotype to be A*24:02- C*07:66-B*40:01-DRB1*12:02 based on
the alleles shared in common by these individuals. However, when
the alleles of HLA-A (A*24:02 excluded) and HLA-DRB1 loci
(DRB1*12:02 excluded) of the individuals bearing C*07:66 are
taken into consideration, C*07:66 does not seem to show strong
linkage with any particular HLA-A or HLA-DRB1 loci allele (Table 1).
In other words, a seemingly random genetic polymorphic combi-
nation of alleles from these loci co-exist with C*07:66. In addition,
the polymorphic nature of C*07:66 is further demonstrated by Cell
Table 2
The deduced HLA-A, HLA-B, HLA-C, HLA-DRB1, and HLA-DQB1 haplotype in associationwith C*07:66was determined based on the HLA typing of the four familymembers with
C*07:66 and a donor (SZBM02) with C*07:66 reported to the IMGT/HLA database. In all cases, C*07:66 can be seen to be linked consistently with A*24:02, B*40:01, DRB1*12:02
and DQB1*03:01 (shaded).
Relationship Donor ID HLA-A* HLA-B* HLA-C* HLA-DRB1* HLA-DQB1*
Mother TB06710 11:01 24:02 40:01 48:01 07:66 15:02 12:02 15:01 03:01 06:01
Son TB07554 02:64 24:02 15:18 40:01 07:04 07:66 04:01 12:02 03:01 03:02
Sister TB09048 02:06 24:02 35:01 40:01 03:03 07:66 12:02 15:01 03:01 06:02
Brother TB09049 11:01 24:02 39:15 40:01 07:66 15:02 12:02 12:02 03:01 03:01
Father TB02350 24:02 24:02 40:01 40:06 07:66 08:01 08:03 12:02 03:01 06:01
Father TB05921 24:02 33:03 40:01 58:01 03:02 07:66 03:01 12:02 02:01 03:01
Son TB05923 24:02 24:02 13:01 40:01 03:04 07:66 04:05 12:02 03:01 04:01
Brother TB07316 01:01 24:02 15:17 40:01 07:01 07:66 12:02 13:02 03:01 06:04
Brother TB07317 01:01 24:02 15:17 40:01 07:01 07:66 12:02 13:02 03:01 06:04
Sister TB07318 24:02 24:02 40:01 40:01 03:04 07:66 12:02 16:02 03:01 06:02
d SZBM02 11:01 24:02 07:02 40:01 07:66 07:67 01:01 12:02 03:01 05:01
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B*40:01 nor an association with A*24:02 at the HLA-A locus nor an
association with DRB1*12:02 at the DRB1 locus. The extensive
polymorphic nature of C*07:66 and its characteristic properties
within the HLA genetic system are mysterious and need to be
further investigated when additional individuals with C*07:66 are
identiﬁed in the future.
Incidentally, the deduced probable C*07:66-associated HLA
haplotype described above is exactly the same as the C*07:66-
associated HLA haplotype identiﬁed by Deng et al [2] in a family
study of a propositus bearing C*07:66. In Table 2, we further
analyzed the HLA typing, including the HLA-DQB1 alleles, of four
family members bearing C*07:66 and a C*07:66 donor reported to
the IMGT/HLA Database. We observed that the commonly shared
C*07:66 in association with HLA-A, HLA-B, HLA-C, and HLA-DRB1
haplotypes is exclusively associated with DQB1*03:01. This leads
us to conclude that the DRB1*12:02 in the haplotype A*24:02-
C*07:66-B*40:01-DRB1*12:02-DQB1*03:01 may exclusively link
with DQB1*03:01 and that this haplotype is most probably
restricted to oriental population individuals.
It is worth mentioning that the most direct and classic method
to determine HLA haplotype is through a family study if test ma-
terial from a number of key family members is available. Alterna-
tively, a population study may be employed if a signiﬁcant number
of unrelated donors is available [4]. However, haplotypes deduced
via a population investigation are generally considered to be likely
or the most probable haplotypes.
The signiﬁcance of determining the ethnicity of individuals with
C*07:66 and its HLA-linked haplotypes is that this information may
be employed in the anthropological investigation of races. Addi-
tionally, it allows search coordinators, using bone marrow donor
registries made up of unrelated donors, to allocate appropriate
unrelated bone marrow hematopoietic stem cell donors to their
patients.
The number of known HLA alleles is increasing exponentially
due to the recent development of DNA-based molecular typing
technology. The outstanding diversity of HLA across ethnic groups
is unique and important. Facilitating an appropriate HLA-match to
an unrelated bone marrow stem cell donor helps to make stem cell
transplantations successful, which depends on the accuracy of HLA
typing. In turn, this requires the spirit and strength to resolve un-
known, ambiguous, and low-incidence genes in the HLA system.
Furthermore, the determination of haplotypes is essential when
matching donor and recipient for unrelated stem cell trans-
plantation since matching at the haplotype level has a betterlikelihood of matching at other loci within the HLA region than
when donors are merely matched at the individual allele level.Acknowledgments
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